Financials
- Market Capitalization 3.39 B
- Employee 624
- Founded 2009
- CEO Chad Robins
- Website www.adaptivebiotech.com
- Headquarter Washington, United States
- FIGI BBG001J2PFF5
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-41.64
市销率
8.9
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1613 | DYN Dyne Therapeutics, Inc. - Common Stock | 23.95 USD | +1.31% | -0.21% | +29.74% | +2.31% | 3.42 B USD | ||
| 1615 | ALMS Alumis Inc. - Common Stock | 27.48 USD | -2.21% | -5.57% | +12.67% | +509.31% | 3.39 B USD | ||
| 1619 | ARQT Arcutis Biotherapeutics, Inc. - Common stock | 27.01 USD | -0.41% | -1.24% | +9.71% | +69.45% | 3.38 B USD | ||
| 1656 | BEAM Beam Therapeutics Inc. - Common Stock | 31.35 USD | +1.13% | -15.11% | +5.03% | +46.91% | 3.23 B USD |